A RANDOMISED CONTROLLED TRIAL TO COMPARE THE INCIDENCE OF SYMPTOMATIC AND ASYMPTOMATIC VENOUS THROMBOEMBOLIC EVENTS FOLLOWING PELVI-ACETABULAR SURGERY IN PATIENTS RECEIVING DIRECT ORAL ANTI COAGULANTS(DOAC) AND THE PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN(LMWH) AS CHEMOPROPHYLAXIS - Nil

AIIMS0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•Patients with renal failure,sepsis ,allergic to dye
•Patients with history of malignant primary or metastatic tumors
•Open fractures or fractures involving lower limb
•Associated Head and Spine injury and abdominal trauma
•Associated vascular injury requiring high dose anticoagulant
•Fracture due to pathological bone lesion at local site.
•Are on long-term anticoagulants.
•Have been diagnosed with a VTE within the last 6 months.
•Are on therapeutic, as opposed to prophylactic, anticoagulants at the time of admission.
•Have an allergy to aspirin or non-steroidal antiinflammatory drugs, or a history of heparin-induced thrombocytopenia, or other medical contraindication to anticoagulants

发起方